Search Results

Ocular Therapeutix, Inc. will host an Investor Day on Thursday, June 13, 2024.

Ocular Therapeutix, Inc., a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration, diabetic retinopathy, and other diseases and conditions of the eye, announced that it will participate at two investor conferences in May:

Ocular Therapeutix, Inc., a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration, diabetic retinopathy, and other diseases and conditions of the eye, reported financial results for the first quarter ended March 31, 2024.